WO2023046321 - PHARMACEUTICAL FORMULATION COMPRISING TACROLIMUS, METHOD FOR THE PREPARATION THEREOF AND USE
National phase entry:
Publication Number
WO/2023/046321
Publication Date
30.03.2023
International Application No.
PCT/EP2022/025445
International Filing Date
27.09.2022
Title **
[English]
PHARMACEUTICAL FORMULATION COMPRISING TACROLIMUS, METHOD FOR THE PREPARATION THEREOF AND USE
[French]
FORMULATION PHARMACEUTIQUE COMPRENANT DU TACROLIMUS, SON PROCÉDÉ DE PRÉPARATION ET SON UTILISATION
Applicants **
PHARMATHEN S.A.
6, Dervenakion Str.
Gr-153 51 Pallini Attikis, GR
Inventors
KARAVAS, Evangelos
6, Dervenakion Str.
Gr-153 51 Pallini Attikis, GR
KOUTRIS, Efthymios
6, Dervenakion Str.
Gr-153 51 Pallini Attikis, GR
KALANTZI, Lida
6, Dervenakion Str.
Gr-153 51 Pallini Attikis, GR
CHAITIDOU, Sotiria
6, Dervenakion Str.
Gr-153 51 Pallini Attikis, GR
LEMONAKIS, Nikos
6, Dervenakion Str.
Gr-153 51 Pallini Attikis, GR
PAPADAKI, Anna
6, Dervenakion Str.
Gr-153 51 Pallini Attikis, GR
BRIEUDES, Vincent
6, Dervenakion Str.
Gr-153 51 Pallini Attikis, GR
KALEZI, Artemis
6, Dervenakion Str.
Gr-153 51 Pallini Attikis, GR
KATSENIS, Athanasios
6, Dervenakion Str.
Gr-153 51 Pallini Attikis, GR
KOTTI, Katerina
6, Dervenakion Str.
Gr-153 51 Pallini Attikis, GR
Priority Data
20210100639
27.09.2021
GR
2116138.5
10.11.2021
GB
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| * | |
International Searching Authority |
EPO
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Translation |
|
Recalculate
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing | 1514 | |
| EPO | Filing, Examination | 8818 | |
| Japan | Filing | 589 | |
| South Korea | Filing | 607 | |
| USA | Filing, Examination | 5310 |
Total: 16838 USD
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Abstract[English]
The present invention relates to a long acting injectable formulation based on combination of biodegradable poly(D,L-lactide-co-glycolide) microparticles comprising different PLGA polymers and Tacrolimus. It also relates to a process for the preparation of microparticles & use thereof.[French]
La présente invention concerne une formulation injectable à action prolongée basée sur la combinaison de microparticules biodégradables de poly(D,L-lactide-co-glycolide) comprenant différents polymères de PLGA et du Tacrolimus. L'invention concerne également un procédé de préparation de microparticules et son utilisation.